Published in J Immunol on December 01, 1987
Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J Exp Med (1991) 10.87
Receptor editing in self-reactive bone marrow B cells. J Exp Med (1993) 5.49
The regulated expression of B lineage associated genes during B cell differentiation in bone marrow and fetal liver. J Exp Med (1993) 3.57
B lymphocytes may escape tolerance by revising their antigen receptors. J Exp Med (1993) 2.78
Light chain replacement: a new model for antibody gene rearrangement. J Exp Med (1995) 1.90
Feedback inhibition of immunoglobulin gene rearrangement by membrane mu, but not by secreted mu heavy chains. J Exp Med (1988) 1.78
Receptor selection in B and T lymphocytes. Annu Rev Immunol (2000) 1.49
Lack of feedback inhibition of V kappa gene rearrangement by productively rearranged alleles. J Exp Med (1991) 1.46
Immature surface Ig+ B cells can continue to rearrange kappa and lambda L chain gene loci. J Exp Med (1993) 1.22
Murine V kappa gene expression does not follow the VH paradigm. J Exp Med (1989) 1.19
Allelic exclusion of immunoglobulin genes: models and mechanisms. Immunol Rev (2010) 1.17
Rearrangement of mouse immunoglobulin kappa deleting element recombining sequence promotes immune tolerance and lambda B cell production. Immunity (2008) 1.14
Early rearrangements of genes encoding murine immunoglobulin kappa chains, unlike genes encoding heavy chains, use variable gene segments dispersed throughout the locus. Proc Natl Acad Sci U S A (1989) 1.14
Receptor editing in self-reactive bone marrow B cells. The Journal of Experimental Medicine. 1993. 177: 1009-1020. J Immunol (2011) 1.10
Human lupus anti-DNA autoantibodies undergo essentially primary V kappa gene rearrangements. EMBO J (1994) 1.10
Functional immunoglobulin light chain genes are replaced by ongoing rearrangements of germline V kappa genes to downstream J kappa segment in a murine B cell line. J Exp Med (1989) 1.04
Deletions of immunoglobulin C kappa region characterized by the circular excision products in mouse splenocytes. J Exp Med (1991) 1.02
B cell receptor editing in tolerance and autoimmunity. Ann N Y Acad Sci (2011) 1.01
Corrective recombination of mouse immunoglobulin kappa alleles in Abelson murine leukemia virus-transformed pre-B cells. Mol Cell Biol (1990) 0.94
Preferential rearrangement of V kappa 4 gene segments in pre-B cell lines. J Exp Med (1990) 0.93
The mouse immunoglobulin kappa light-chain genes are located in early- and late-replicating regions of chromosome 6. Mol Cell Biol (1990) 0.89
A single pre-B cell can give rise to antigen-specific B cells that utilize distinct immunoglobulin gene rearrangements. J Exp Med (1990) 0.88
Restricted immunoglobulin variable region (Ig V) gene expression accompanies secondary rearrangements of light chain Ig V genes in mouse plasmacytomas. J Exp Med (1999) 0.85
The complexity of expressed kappa light chains in egg-laying mammals. Immunogenetics (2004) 0.80
Restricted kappa chain expression in early ontogeny: biased utilization of V kappa exons and preferential V kappa-J kappa recombinations. J Exp Med (1993) 0.78
Violations of the 12/23 rule at the mouse immunoglobulin kappa locus, including V kappa-V kappa rearrangement. Mol Immunol (2009) 0.77
Multiple factors influence the contribution of individual immunoglobulin light chain genes to the naïve antibody repertoire. BMC Immunol (2014) 0.76
Conserved cryptic recombination signals in Vkappa gene segments are cleaved in small pre-B cells. BMC Immunol (2009) 0.75
Direct evidence for intrastrand DNA inversion of kappa immunoglobulin gene segments in two murine plasmacytomas. Nucleic Acids Res (1989) 0.75
Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin. Proc Natl Acad Sci U S A (1984) 5.49
Receptor editing: an approach by autoreactive B cells to escape tolerance. J Exp Med (1993) 5.49
Aberrant rearrangements contribute significantly to the allelic exclusion of immunoglobulin gene expression. Nature (1981) 4.78
Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation. J Exp Med (1990) 4.46
Genetics of the antibody response to dextran in mice. Science (1972) 4.37
Identification and nucleotide sequence of a diversity DNA segment (D) of immunoglobulin heavy-chain genes. Nature (1981) 4.19
Inter- and intraclonal diversity in the antibody response to influenza hemagglutinin. J Exp Med (1985) 3.54
Transcription of mouse kappa chain genes: implications for allelic exclusion. Proc Natl Acad Sci U S A (1980) 3.38
Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice. Nature (1991) 3.32
Recombination between an expressed immunoglobulin heavy-chain gene and a germline variable gene segment in a Ly 1+ B-cell lymphoma. Nature (1986) 3.24
Rearrangement of genetic information may produce immunoglobulin diversity. Nature (1979) 2.84
B lymphocytes may escape tolerance by revising their antigen receptors. J Exp Med (1993) 2.78
Immunoglobulin heavy chain gene replacement: a mechanism of receptor editing. Immunity (1995) 2.56
Genetic and structural evidence for antigen selection of anti-DNA antibodies. Annu Rev Immunol (1994) 2.45
Residues that mediate DNA binding of autoimmune antibodies. J Immunol (1993) 2.37
DNA between variable and joining gene segments of immunoglobulin kappa light chain is frequently retained in cells that rearrange the kappa locus. Proc Natl Acad Sci U S A (1982) 2.36
Genetic control of antibody variable regions. Cold Spring Harb Symp Quant Biol (1977) 2.35
The joining of V and J gene segments creates antibody diversity. Nature (1980) 2.28
Immunochemical analysis of the cross-reacting idiotypes of mouse myeloma proteins with anti-dextran activity and normal anti-dextran antibody. Proc Natl Acad Sci U S A (1973) 2.21
Genes for immunoglobulin heavy chain and serum prealbumin protein are linked in mouse. Nature (1975) 2.01
Revising B cell receptors. J Exp Med (2000) 1.96
Ig H and L chain contributions to autoimmune specificities. J Immunol (1991) 1.96
Light chain replacement: a new model for antibody gene rearrangement. J Exp Med (1995) 1.90
Editors and editing of anti-DNA receptors. Immunity (2001) 1.90
The site and stage of anti-DNA B-cell deletion. Nature (1995) 1.87
Multiplicity of germline genes specifying a group of related mouse kappa chains with implications for the generation of immunoglobulin diversity. Nature (1979) 1.85
Editing disease-associated autoantibodies. Immunity (1997) 1.81
Mouse lambda-chain sequences. Proc Natl Acad Sci U S A (1973) 1.78
Genetics of mouse antibodies. I. Linkage of the dextran response locus, VH-DEX, to allotype. Eur J Immunol (1975) 1.68
Deletion and editing of B cells that express antibodies to DNA. J Immunol (1994) 1.62
A Shannon entropy analysis of immunoglobulin and T cell receptor. Mol Immunol (1997) 1.58
Light chain contribution to specificity in anti-DNA antibodies. J Immunol (1995) 1.39
Somatic mutation and light chain rearrangement generate autoimmunity in anti-single-stranded DNA transgenic MRL/lpr mice. J Exp Med (1999) 1.36
Structural patterns in anti-DNA antibodies from MRL/lpr mice. Cold Spring Harb Symp Quant Biol (1989) 1.35
The BALB/c secondary response to the Sb site of influenza virus hemagglutinin. Nonrandom silent mutation and unequal numbers of VH and Vk mutations. J Immunol (1990) 1.30
Light chain editing in kappa-deficient animals: a potential mechanism of B cell tolerance. J Exp Med (1994) 1.29
Chromosomal locations of mouse immunoglobulin genes. Proc Natl Acad Sci U S A (1978) 1.29
Immunoglobulins with hapten-binding activity: structure-function correlations and genetic implications. Eur J Immunol (1978) 1.22
Mouse immunoglobulin heavy chains are coded by multiple germ line variable region genes. Proc Natl Acad Sci U S A (1974) 1.22
New methods for the treatment of lunatomalacia. Reconstr Surg Traumatol (1969) 1.22
Immunochemical analysis of the idiotypes of mouse myeloma proteins with specificity for levan or dextran. J Exp Med (1974) 1.20
Heavy-chain class switch does not terminate somatic mutation. J Exp Med (1990) 1.16
Structural basis for autoantibody recognition of phosphatidylserine-beta 2 glycoprotein I and apoptotic cells. Proc Natl Acad Sci U S A (2001) 1.15
Origins of anti-DNA antibodies and their implications for B-cell tolerance. Ann N Y Acad Sci (1995) 1.15
Aberrant rearrangement of the kappa light-chain locus involving the heavy-chain locus and chromosome 15 in a mouse plasmacytoma. Nature (1983) 1.14
Reorganization and expression of immunoglobulin genes: status of allelic elements. Cold Spring Harb Symp Quant Biol (1981) 1.12
Genetics of mouse antibodies. II. Recombination between VH genes and allotype. Eur J Immunol (1975) 1.10
[Errors and hazards in total hip-joint prosthesis]. Z Orthop Ihre Grenzgeb (1971) 1.10
Selective pathogenicity of murine rheumatoid factors of the cryoprecipitable IgG3 subclass. Int Immunol (1992) 1.09
Regulation of anti-DNA B cells in recombination-activating gene-deficient mice. J Exp Med (1998) 1.09
Antibody gene linkage studies in (NZB X C58) recombinant-inbred lines. J Immunol (1980) 1.09
Myeloma proteins from NZB and BALB/c mice: structural and functional differences. Proc Natl Acad Sci U S A (1979) 1.07
Genetic polymorphism at the kappa chain locus in mice: comparisons of restriction enzyme hybridization fragments of variable and constant region genes. Immunogenetics (1985) 1.02
Independent segregation of NZB immune abnormalities in NZB x C58 recombinant inbred mice. Eur J Immunol (1982) 1.02
[Simple procedure for the surgical management of habitual peroneal tendon luxation]. Z Orthop Ihre Grenzgeb (1968) 0.98
The idiotypes of V kappa 21 light chains. Ann Immunol (Paris) (1984) 0.97
Amplification of immunoglobulin lambda constant genes in populations of wild mice. Nature (1982) 0.96
[Stimulation of bone formation using electrical current]. Hefte Unfallheilkd (1973) 0.92
Replication pattern in XXY cells with fra(X). Hum Genet (1982) 0.92
Expression of kappa chains of the V kappa 21 group in Mus musculus and related species. Mol Immunol (1981) 0.91
[Total alloarthroplasty following arthrodesis]. Z Orthop Ihre Grenzgeb (1971) 0.91
[Advances in the technique of arthrodesis of the hip]. Munch Med Wochenschr (1968) 0.90
[Chondromalacia patellae in the active sportsman]. Z Orthop Ihre Grenzgeb (1968) 0.89
A solution to the rheumatoid factor paradox: pathologic rheumatoid factors can be tolerized by competition with natural rheumatoid factors. J Immunol (1997) 0.89
[Potentials in bone on electric stimulation (author's transl)]. Z Orthop Ihre Grenzgeb (1973) 0.88
[Injuries of the knee ligaments: suture or plastic repair]. Arch Orthop Unfallchir (1972) 0.87
[The speed of nerve-conduction after micro-surgical suture of the tibial nerve of the rabbit (author's transl)]. Z Orthop Ihre Grenzgeb (1975) 0.87
Plasmacytomas of the NZB mouse. J Immunol (1978) 0.87
[The regression of neurological symptoms following intervertebral disk surgery]. Z Orthop Ihre Grenzgeb (1967) 0.86
[Injury of the distal tibiofibular syndesmosis, its diagnosis and treatment]. Z Orthop Ihre Grenzgeb (1967) 0.85
Number and size of antral follicles as predictive factors in vitro fertilization and embryo transfer. J Assist Reprod Genet (2000) 0.84
Constitutive secretion of transgene-encoded IgG2b autoantibodies leads to symptoms of autoimmune disease. J Immunol (1995) 0.84
The structural basis of antigenic determinants on V kappa 21 light chains. Mol Immunol (1981) 0.83
[Radius-shortening osteotomy in os lunatum malacia]. Munch Med Wochenschr (1967) 0.82
[Experience with Chiari pelvic osteotomy in the adult (author's transl)]. Z Orthop Ihre Grenzgeb (1973) 0.82
Fixing mismatches. Science (1998) 0.81
[Results and complications following endoprosthesis operations on the hip]. Z Orthop Ihre Grenzgeb (1969) 0.80
[Arthrodesis of the wrist joint]. Zentralbl Chir (1975) 0.78
A complex translocation at the murine kappa light-chain locus. Mol Cell Biol (1987) 0.78
[Synovectomy on the hip joint]. Z Orthop Ihre Grenzgeb (1968) 0.77
[Diagnosis and treatment of lumbar intervertebral disk prolapse]. Z Orthop Ihre Grenzgeb (1966) 0.77
[Early dislocation of Weber-Huggler prothesis (author's transl)]. Arch Orthop Unfallchir (1973) 0.76
[Indication and technical details of valgisation and medial displacement-osteotomy for treatment of instable pertrochanteric fractures on old patients]. Arch Orthop Unfallchir (1972) 0.75
[Surgical reconstruction of the injured upper ankle joint--correct and incorrect technics]. Arch Orthop Unfallchir (1973) 0.75
[Experimental experience with autologous nerve-transplantation in rabbits (author's transl)]. Arch Orthop Unfallchir (1977) 0.75
Total replacement of the femur and its adjacent joints. Arch Orthop Trauma Surg (1979) 0.75
[Piezoelectric potentials in the intact and osteomized tibia (author's transl)]. Arch Orthop Unfallchir (1974) 0.75
Is the hypothesis alive that IgM anti-IgG1 rheumatoid factor specificity is determined by framework regions? Eur J Immunol (1990) 0.75
[Experiences with dimer X for lumbosacral-myelography (author's transl)]. Arch Orthop Unfallchir (1975) 0.75
[Fractures of the forearm in children; operative treatment (author's transl)]. Zentralbl Chir (1979) 0.75
A search for hapten-binding mouse plasmacytoma proteins. Eur J Immunol (1979) 0.75
Comparisons of myeloma proteins from NZB and BALB/c mice: structural and functional differences of heavy chains. J Immunol (1979) 0.75
[Pertrochanteric fracture in the aged]. Hefte Unfallheilkd (1975) 0.75
[Total replacement of the shoulder joint]. Zentralbl Chir (1975) 0.75
[Principles and methods of electric stimulation of bone formation in man]. Zentralbl Chir (1978) 0.75
[Surgical indications in forearm shaft fractures in children]. Hefte Unfallheilkd (1978) 0.75
[Treatment of ankle-joint fractures in the aged]. Hefte Unfallheilkd (1975) 0.75
[The treatment of calcaneal fractures (author's transl)]. Unfallheilkunde (1979) 0.75